Although certain phosphor epitopes of tau may be useful, taumarkers may not generally be ideal for distinguishing between Alzheimer’s disease(AD) and CTE, as both are tauopathies (21).Currently, no adequate biomarkers exist to differentiate CTE from other forms ofneurodegeneration. The gene discussed is MAPT; the disease is Alzheimer disease.